Edesa Biotech EDSA Income Statement (2013-2026)

NASDAQ EDSA
$4.76 -0.99 (-17.22%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Aug2013 Dec2013 Aug2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity) (Quarter)
1.89M1.90M1.93M2.21M2.21M2.38M2.76M2.87M2.98M3.08M3.16M3.22M3.25M3.25M3.47M5.31M7.02M5.68M8.33M9.64M
Revenue & cost
Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)
4.46M4.13M3.95M3.04M4.55M1.79M1.36M1.46M1.03M0.95M0.70M1.18M0.90M0.10M1.02M0.48M0.94M1.23M1.12M3.96M
Selling, General & Administrative (Quarter)
1.61M1.36M1.21M1.53M1.25M1.04M1.02M0.95M1.04M1.42M1.15M1.04M1.04M0.90M0.88M1.15M0.96M1.24M1.22M1.56M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
6.07M5.48M5.16M4.58M5.80M2.84M2.38M2.41M2.06M2.37M1.86M2.22M1.93M1.00M1.90M1.64M1.90M2.47M2.34M5.52M
Operating Income (Quarter)
-6.07M-5.48M-5.16M-4.58M-5.80M-2.84M-2.38M-2.41M-2.06M-2.37M-1.86M-2.22M-1.93M-1.00M-1.90M-1.64M-1.90M-2.47M-2.34M-5.52M
EBIT (Quarter)
-6.07M-5.48M-5.16M-4.58M-5.80M-2.84M-2.38M-2.41M-2.06M-2.37M-1.86M-2.22M-1.93M-1.00M-1.90M-1.64M-1.90M-2.47M-2.34M-5.52M
Non-operating items
Interest & Investment Income (Quarter)
0.00M0.01M0.01M0.00M0.02M0.04M0.05M0.09M0.08M0.07M0.06M0.04M0.03M0.02M0.00M265.00572.0055.0047.00275.00
Other Non Operating Income (Quarter)
0.00M10.28M-0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.00M-0.00M-0.00M-0.07M-0.02M-0.00M-0.01M0.00M
Non Operating Income (Quarter)
1.31M1.80M0.78M0.01M0.01M0.02M0.04M0.08M0.08M0.65M0.18M0.36M0.26M0.04M0.28M0.05M0.15M0.24M0.09M0.11M
Net income details
EBT (Quarter)
-4.76M-3.69M-5.26M-4.57M-5.79M-2.81M-4.10M-2.33M-1.98M-1.72M-3.47M-1.86M-1.67M-0.96M-2.00M-1.59M-1.75M-2.23M-2.44M-5.41M
Tax Provisions (Quarter)
-3.54M800.00-4.65M800.000.34M800.000.15M800.000.20M
Profit After Tax (Quarter)
-4.59M-3.69M-4.35M-4.57M-5.75M-2.82M-2.33M-2.33M-1.95M-1.77M-1.68M-1.86M-1.67M-0.98M-1.62M-1.65M-1.75M-2.39M-2.25M-5.41M
Income from Continuing Operations (Quarter)
-4.76M-0.15M-5.26M-4.57M-5.79M1.84M-4.10M-2.33M-1.98M-2.06M-3.47M-1.86M-1.67M-1.11M-2.00M-1.59M-1.75M-2.43M-2.44M-5.41M
Consolidated Net Income (Quarter)
-4.76M-0.15M-5.26M-4.57M-5.79M1.84M-4.10M-2.33M-1.98M-2.06M-3.47M-1.86M-1.67M-1.11M-2.00M-1.59M-1.75M-2.43M-2.44M-5.41M
Income towards Parent Company (Quarter)
-4.76M-0.15M-5.26M-4.57M-5.79M1.84M-4.10M-2.33M-1.98M-2.06M-3.47M-1.86M-1.67M-1.11M-2.00M-1.59M-1.75M-2.43M-2.44M-5.41M
Net Income towards Common Stockholders (Quarter)
-4.76M-0.15M-5.26M-4.57M-5.79M1.84M-4.10M-2.33M-1.98M-2.06M-3.47M-1.86M-1.67M-1.11M-2.00M-1.59M-1.75M-2.43M-2.44M-5.41M
Additional items
EPS (Basic) (Quarter)
-2.51-0.09-2.76-2.31-2.620.77-1.56-0.82-0.68-0.72-1.11-0.58-0.52-0.35-0.60-0.30-0.25-0.43-0.31-0.60
EPS (Diluted) (Quarter)
-158.53-4.97-175.09-152.19-192.7561.19-136.70-77.75-66.11-68.58-115.60-62.00-55.56-36.91-66.56-52.97-58.27-80.87-81.35-180.12
Shares Outstanding (Quarter)
1.89M1.73M1.91M1.98M2.21M2.38M2.63M2.85M2.93M2.86M3.13M3.19M3.22M3.20M3.35M5.31M7.02M5.68M7.97M9.01M
Shares Outstanding (Diluted) (Quarter)
0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M0.03M
EBITDA (Quarter)
-6.07M-5.48M-5.16M-4.58M-5.80M-2.84M-2.38M-2.41M-2.06M-2.37M-1.86M-2.22M-1.93M-1.00M-1.90M-1.64M-1.90M-2.47M-2.34M-5.52M
Interest Expenses (Quarter)
1.98M11.62M0.10M4.58M1.88M15.09M1.78M1.78M0.12M0.08M1.67M1.67M0.10M0.08M0.10M0.10M0.10M0.10M0.17M
Tax Rate (Quarter)
95.95-0.02165.29-0.03-19.65-0.04-15.20-0.05-8.94